Coding proposal on phenotyping heart failure with preserved ejection fraction: A practical tool for facilitating etiology-oriented therapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Comorbidities and incidence of heart failure with preserved ejection fraction: a systematic review and meta-analysis of cohort studies.BMJ open · 2025
   Pooled it
2. On the search for the right definition of heart failure with preserved ejection fraction.Cardiology journal · 2020
   Trial
3. Phenotypes and Clinical Outcome of Heart Failure With Preserved Ejection Fraction Patients in China: Findings From the Chinese Cardiovascular Association Database-Heart Failure Center Registry.MedComm · 2026
   Article
4. Application ofAmerican journal of translational research · 2026
   Article
5. The treatment of selected traditional Chinese medicine prescriptions and their metabolites for heart failure with preserved ejection fraction from basic science discovery to the clinic.Frontiers in pharmacology · 2026
   Review
6. The prognostic value of HFA-PEFF score in connective tissue disease-associated PAH: evidence from a cohort study.BMC cardiovascular disorders · 2025
   Observational
7. Nitazoxanide protects against heart failure with preserved ejection and metabolic syndrome induced by high-fat diet (HFD) plus L-NAME "two-hit" in mice.Acta pharmaceutica Sinica. B · 2025
   Article
8. The effect of guideline-directed medicine on patients with new-onset heart failure following acute myocardial infarction.Frontiers in cardiovascular medicine · 2025
   Article
9. Decreased plasma ELABELA level as a novel screening indicator for heart failure: a cohort and observational study.Scientific reports · 2024
   Observational
10. Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
11. Clinical Usefulness of Speckle-Tracking Echocardiography in Patients with Heart Failure with Preserved Ejection Fraction.Diagnostics (Basel, Switzerland) · 2023
    Review
12. Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction.Reviews in cardiovascular medicine · 2023
    Review
13. Sex differences and related estrogenic effects in heart failure with preserved ejection fraction.Heart failure reviews · 2023
    Review
14. Phenotypes of Cardiovascular Diseases: Current Status and Future Perspectives.Phenomics (Cham, Switzerland) · 2021
    Review
15. Predictive value of HESC heart failure · 2021
    Article
16. Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction.Frontiers in cardiovascular medicine · 2021
    Article
17. Deciphering the Protein, Modular Connections and Precision Medicine for Heart Failure With Preserved Ejection Fraction and Hypertension Based on TMT Quantitative Proteomics and Molecular Docking.Frontiers in physiology · 2021
    Article
18. Prognostic value of serum hyponatremia for outcomes in patients with heart failure with preserved ejection fraction: An observational cohort study.Experimental and therapeutic medicine · 2020
    Article
19. Left ventricular ejection fraction… What else?Cardiology journal · 2020
    Article

Corrections and comments

• Commented on by
  Left ventricular ejection fraction… What else?2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as